Form 4 for CVS CVS Health
Accepted 2026-04-02 16:57:02 ET · period of report 2026-03-31 · accession 0000064803-26-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-02 16:57 | 2026-03-31 | CVS | Newman Brian | EVP, CFO | A - Grant | $71.82 | +19.5K | 41.4K | +89% | +$1.40M |
| D | 2026-04-02 16:57 | 2026-03-31 | CVS | Newman Brian | EVP, CFO | A - Grant | $71.82 | +125.7K | 125.7K | New | +$9.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSUs) | 2026-03-31 | A | A | 19,493 | $71.82 | 41,354 | D | — | — | (F1) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| 2 | Derivative | Stock Option | 2026-03-31 | A | A | 125,748 | $71.82 | 125,748 | D | $71.82 · 2027-03-31 to 2036-03-31 | 125,748 Common Stock | (F2) Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |